Objective: To compare the prevalence of postpartum depression (PPD) symptoms between high-income countries (HIC) and low- and middle-income countries (LMIC) during the COVID-19 pandemic. Methods: The PubMed, Embase, Virtual Health Library, Scopus, Web of Science, PsycINFO, and CINAHL databases were searched until October 2022 for studies that collected data during the pandemic. The metaprop command was used in the Stata statistical software version 12.0 to run a random-effects meta-analysis. Results: A total of 15 studies with 4,788 postpartum women were included. The overall prevalence of PPD symptoms was 31% (95%CI 21.85-40.99). The pooled prevalence of PPD symptoms among women from HIC (30.5% [95%CI 16.95-46.02]) did not differ significantly from that of women from LMIC (31.5% [95%CI 19.26-45.15]). However, studies that analyzed women up to 1 month after childbirth reported a lower prevalence of PPD symptoms (17.5% [95%CI 9.85-26.62]) compared to those that observed them up to 1 year after childbirth (38.3% [95%CI 33.96-42.83]). Conclusions: The prevalence of PPD symptoms was high across countries, regardless of human development index. This condition must be regularly tracked worldwide to assess, discuss, and recommend more assertive steps that may be implemented to address it based on the particular characteristics of each country.
Objective: To compare the presence of neutralizing antibodies against SARS-CoV-2 found in the breast milk and blood of vaccinated lactating women with those not vaccinated.
Objective: We aimed to evaluate the association between pre-pregnancy excess weight and the adequacy of the ω-6/ω-3 ratio using a directed acyclic graph (DAG) to guide the selection of potential confounders. Methods: We conducted a cross-sectional study with 89 lactating women visiting a breast milk bank in Rio de Janeiro, Brazil. Pre-pregnancy excess weight was assessed using the body mass index according to World Health Organization criteria. ω-6 and ω-3 levels were determined by gas chromatography, and their ratios were calculated and categorized, with a ratio of greater than 10 being considered inadequate in accordance with dietary intake recommendations for these fatty acids. A DAG was constructed to identify a minimally sufficient set of confounders, including maternal age, socioeconomic status, parity, interbirth interval and food consumption patterns. Prevalence ratios were estimated using Poisson regression with robust variance. Results: The mean ω-6/ω-3 ratio was 10.8. Prevalence of inadequate ω-6/ω-3 ratio was higher in women with pre-pregnancy excess weight compared to women with normal pre-pregnancy weight. After adjusting for the confounders identified by the DAG, prevalence of inadequate ω-6/ω-3 ratio was higher among women with pre-pregnancy excess weight (PR = 1.35; 95% CI: 1.02–1.78). Conclusions: Pre-pregnancy excess weight is associated with an unfavorable breast milk lipid profile characterized by an imbalance in the ω-3 to ω-6 essential fatty acid ratio. The use of a DAG-based approach enables parsimonious and theoretically grounded adjustment for potential confounders, contributing to greater robustness of the findings. Our results underscore the importance of nutritional care strategies during the preconception period to promote maternal and child health.
Resumen El objetivo es comparar el porcentaje de anticuerpos neutralizantes frente a las variantes Wuhan y Omicron en la leche y la sangre de lactantes inmunizados contra el SRAS-CoV-2 en función del número de dosis y las tecnologías vacunales utilizadas. Estudio transversal realizado en 2022 con 214 mujeres lactantes inmunizadas contra COVID-19 con vacunas de ARNm, vector viral no replicante o virus completo inactivado. Datos recolectados mediante cuestionario estandarizado y muestras de leche materna y sangre. Anticuerpos detectados por el método ELISA. Se consideró un nivel de significación del 5%. El porcentaje de anticuerpos fue mayor en sangre que en leche para las variantes Wuhan (sangre-91-3%/leche-23-1%) y Omicron (sangre-83-7%/leche-15-2%). Entre las mujeres que recibieron tres o más dosis, la sangre mostró porcentajes más elevados para las variantes Wuhan y Omicron. En la leche, aunque no se encontró disparidad en el porcentaje de anticuerpos, la probabilidad de que hubiera anticuerpos fue mayor que en la sangre para ambas variantes. Las tecnologías de vacunas dieron lugar a diferencias significativas en la presencia de anticuerpos en la leche, pero no en la sangre a lo largo del tiempo para la variante Omicron. No se observaron diferencias en el caso de la variante Wuhan. La protección conferida por los anticuerpos presentes en la leche duró más que en la sangre.
The aim is to compare the percentage of antibodies with neutralizing potential to Wuhan and Omicron variants in the milk and blood of lactating women immunized for SARS-CoV-2 based on the number of doses, vaccine technologies used. Cross-sectional study conducted in 2022 with 214 lactating women vaccinated for COVID-19 with mRNA, non-replicating viral vector or inactivated whole virus vaccines. Data gathered via standardized questionnaire, and samples of breast milk and blood. Antibodies detected by the ELISA method. A significance level of 5% was considered. Blood had higher neutralizing antibodies percentage than milk for Wuhan (blood-91·3%/milk-23·1%) and Omicron (blood-83·7%/milk-15·2%) variants. Women receiving three or more doses had higher blood antibody percentages for Wuhan and Omicron variants. In milk, no disparity in the percentage of antibodies was found, but the probability of antibodies’ presence was higher than in blood for both variants. Vaccine technologies led to significant differences in the presence of antibodies in milk but not in blood over time for Omicron variant. No difference was observed for Wuhan variant. Protection conferred by antibodies present in milk lasted longer than in blood.